Man Group PLC Praxis Precision Medicines, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.8 - $4.98 $225,248 - $1.4 Million	-281,561 Reduced 91.82%	25,100 $20,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $126,339 - $2.45 Million	67,202 Added 28.06%	306,661 $729,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $598,647 - $9.09 Million	239,459 New	239,459 $544,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $35,525 - $230,202	-20,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $207,263 - $411,887	20,300 New	20,300 $207,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.